Nelson Advisors referenced in Forbes article 'Kintsugi CEO Says Building AI For Healthcare Is Financially Unsustainable For Startups'
NA
Nelson Advisors has been referenced in the Forbes article 'Kintsugi CEO Says Building AI For Healthcare Is Financially Unsustainable For Startups'
Building artificial intelligence (AI) for healthcare has never been more technically feasible — or more financially punishing. As generative AI innovation and adoption accelerate, even startups with clinically validated models, peer-reviewed trials, and enterprise demand are discovering that scientific proof no longer guarantees commercial survival. Regulatory clearance does.
Kintsugi, a mental health AI startup that developed clinically validated voice biomarkers capable of detecting depression and anxiety from short clips of free-form speech, is the latest example. After raising roughly $30 million, completing years of clinical research, and conducting a pivotal study of about 1,600 participants over four years, the California-based company recently shut down its operations.
“When you're building at the intersection of AI and a highly regulated healthcare space, venture investors still expect you to be at $100 million in ARR by year ten—and now, with the acceleration driven by AI and LLMs, they expect that by year three or five. But in healthcare, you can’t even sell your commercial product until you are FDA cleared,” Grace Chang, founder and CEO of Kintsugi, told me. “That fundamental mismatch between venture timelines and regulatory timelines creates enormous structural tension for startups like ours.”
The decision reflects both a mission-driven exit and a structural warning for the AI healthcare sector. Recent industry data shows healthcare AI shutdowns rose more than 25% between 2024 and 2025 amid a broader funding contraction, with mental health AI companies facing particularly intense scrutiny around clinical efficacy and regulatory compliance. New legislations have further tightened oversight.
The state of Illinois enacted the Wellness and Oversight for Psychological Resources Act (HB 1806) in Aug. 2025, signed by Gov. J.B. Pritzker, prohibiting the use of AI in therapy and psychotherapy services. Industry analysts estimate that only about 16% of mental health AI tools have undergone rigorous clinical testing, raising concerns among regulators about real-world effectiveness.